Treatment of Dysphagia Using the Mendelsohn Maneuver
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00592761|
Recruitment Status : Completed
First Posted : January 14, 2008
Results First Posted : July 20, 2010
Last Update Posted : March 20, 2018
|Condition or disease||Intervention/treatment||Phase|
|Stroke Dysphagia||Behavioral: Mendelsohn Maneuver||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||18 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Treatment of Dysphagia Using the Mendelsohn Maneuver|
|Study Start Date :||July 2003|
|Actual Primary Completion Date :||September 2008|
|Actual Study Completion Date :||September 2008|
Experimental: Within subjects treatment, no-treatment
Within subject, treatment and no-treatment periods. Each participant served as his/her own control in this AABB/BBAA alternating treatment conditions design. Results were also compared across groups (treatment v. no-treatment).
Behavioral: Mendelsohn Maneuver
Mendelsohn Maneuver with Surface Electromyography
- Change in Duration of Superior Hyolaryngeal Movement [ Time Frame: baseline and six weeks ]Change in duration of superior elevation of hyoid bone.
- Change in Duration of Hyoid Maximum Anterior Excursion [ Time Frame: Baseline and 6 weeks ]Change in the duration of maximum anterior movement of the hyoid bone during swallowing.
- Change in Oral Intake Ability [ Time Frame: Baseline and 6 weeks ]Oral Intake Ability was measure with the Dysphagia Outcome and Severity Scale. A 7 is normal and a 1 is complete inability to consume any food safely. The means reported for treatment and no treatment periods are mean changes in scores throughout the period.
- Change in Duration of Opening of Upper Esophageal Sphincter [ Time Frame: Baseline and 6 weeks ]Change in duration of pre- and post-treatment duration of UES opening.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00592761
|United States, Arkansas|
|UArkansas/UAMS Medical Center|
|Little Rock, Arkansas, United States, 72035|
|Principal Investigator:||Gary H McCullough, Ph.D.||University of Arkansas|